Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22806212 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Down Syndrome Memantine Follow-up Study
Conditions: Down Syndrome;   Intellectual Disability
Interventions: Drug: Memantine;   Drug: Placebo
2 Completed
Has Results
Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Condition: Down Syndrome
Interventions: Drug: Memantine;   Drug: Placebo

Indicates status has not been verified in more than two years